“…Although the benefits of cardiac resynchronization therapy (CRT) have been demonstrated in clinical trials, 1 , 2 , 3 , 4 the response rate to CRT in real-world cohorts with guideline-based indications 5 remains suboptimal. 6 Although models have been developed to predict response to CRT, 7 , 8 , 9 , 10 the field lacks a noninvasive, real-time, accurate simulation to determine which patients would have a favorable response to CRT and the degree of response to be expected. Some approaches such as the ECG Belt (Medtronic plc., Mounds View, MN; an array of 40 electrodes around the mid torso) provide feedback about the effectiveness of resynchronization only after the left ventricular (LV) pacing lead has been implanted.…”